{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:39:25Z","timestamp":1792726765769,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004835","name":"Zhejiang University","doi-asserted-by":"publisher","award":["BL202221"],"award-info":[{"award-number":["BL202221"]}],"id":[{"id":"10.13039\/501100004835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008235","name":"School of Medicine, University of Utah Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008235","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZCLKLY26H0201"],"award-info":[{"award-number":["ZCLKLY26H0201"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvir.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jvir.2026.108987","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:57:08Z","timestamp":1785455828000},"page":"108987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Drug-Eluting Stents versus Drug-Coated Balloons Plus Bare-Metal Stents for the Treatment of Femoropopliteal Artery Lesions: 2-Year Outcomes from the TALENT Study"],"prefix":"10.1016","volume":"37","author":[{"given":"Zhengyuan","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4812-7353","authenticated-orcid":false,"given":"Chunshui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianrui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zibo","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2441-7893","authenticated-orcid":false,"given":"Yanbo","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2026.108987_bib1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1186\/s12872-025-05055-2","article-title":"Global burden of peripheral arterial disease and its risk factors, 1990-2021","volume":"25","author":"Fu","year":"2025","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jvir.2026.108987_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejvs.2023.08.067","article-title":"Editor\u2019s choice\u2014European society for vascular surgery (ESVS) 2024 clinical practice guidelines on the management of asymptomatic lower limb peripheral arterial disease and intermittent claudication","volume":"67","author":"Nordanstig","year":"2024","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvir.2026.108987_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pcad.2021.02.004","article-title":"Femoral-popliteal peripheral artery disease: from symptom presentation to management and treatment controversies","volume":"65","author":"Krawisz","year":"2021","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jvir.2026.108987_bib4","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.jvir.2023.12.574","article-title":"Mortality, safety, and effectiveness of paclitaxel-containing balloons and stents in the femoropopliteal artery: systematic review and meta-analysis of randomized controlled trials since 2018","volume":"35","author":"Briody","year":"2024","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2026.108987_bib5","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jvir.2023.03.014","article-title":"Real-world safety analysis of paclitaxel devices used for the treatment of peripheral artery disease","volume":"34","author":"Dani","year":"2023","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2026.108987_bib6","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/j.jcin.2025.07.034","article-title":"3-year outcomes of drug-eluting stent vs drug-coated balloon for femoropopliteal artery lesions: propensity score-matched real-world study","volume":"18","author":"Nakama","year":"2025","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvir.2026.108987_bib7","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s00270-021-02901-6","article-title":"24-month efficacy and safety results from Japanese patients in the IMPERIAL randomized study of the Eluvia drug-eluting stent and the Zilver PTX drug-coated stent","volume":"44","author":"Iida","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2026.108987_bib8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00270-019-02355-x","article-title":"Japanese patients treated in the IMPERIAL randomized trial comparing Eluvia and Zilver PTX stents","volume":"43","author":"Soga","year":"2020","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2026.108987_bib9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ejvs.2022.05.046","article-title":"Drug eluting versus covered stent for femoropopliteal artery lesions: results of the ULTIMATE study","volume":"64","author":"Ichihashi","year":"2022","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvir.2026.108987_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1035659","article-title":"A prospective, multicenter, real-world observational study evaluating the impact of tibial runoff on clinical outcomes after endovascular therapy for femoropopliteal lesions: research protocol","volume":"9","author":"Liu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jvir.2026.108987_bib11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ejvs.2008.06.020","article-title":"Clinical endpoints in peripheral endovascular revascularization trials: a case for standardized definitions","volume":"36","author":"Diehm","year":"2008","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvir.2026.108987_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102410","article-title":"Prognostic and predictive value of ultrasound-based estimated ankle brachial pressure index at early follow-up after endovascular revascularization of chronic limb-threatening ischaemia: a prospective, single-centre, service evaluation","volume":"68","author":"Rodway","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jvir.2026.108987_bib13","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.jacc.2018.03.008","article-title":"Major adverse limb events and mortality in patients with peripheral artery disease: the COMPASS trial","volume":"71","author":"Anand","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvir.2026.108987_bib14","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1097\/SLA.0000000000005477","article-title":"Measuring quality of life in chronic limb-threatening ischemia patients and informal carers: a scoping review","volume":"276","author":"Shan","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.jvir.2026.108987_bib15","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.123.013084","article-title":"Five-year safety and effectiveness of paclitaxel drug-coated balloons alone or with provisional bare metal stenting for real-world femoropopliteal lesions: IN.PACT global study subgroup analysis","volume":"17","author":"Ansel","year":"2024","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jvir.2026.108987_bib16","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"key":"10.1016\/j.jvir.2026.108987_bib17","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.ejvs.2025.03.010","article-title":"Editor\u2019s choice\u2014comparative analysis of three year results of two paclitaxel related stents for the management of femoropopliteal disease in a real world setting","volume":"69","author":"Shibata","year":"2025","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvir.2026.108987_bib18","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(18)32262-1","article-title":"A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial","volume":"392","author":"Gray","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jvir.2026.108987_bib19","doi-asserted-by":"crossref","DOI":"10.1161\/HYP.0000000000000257","volume":"82","author":"Jones","year":"2025","journal-title":"Hypertension"},{"key":"10.1016\/j.jvir.2026.108987_bib20","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1177\/15266028241267759","article-title":"High-dose drug-coated balloon versus polymer-based drug-eluting stent for femoropopliteal artery disease treatment","volume":"33","author":"Soga","year":"2026","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jvir.2026.108987_bib21","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1093\/eurheartj\/ehag070","article-title":"Great debate: drug-coated balloons are preferable to drug-eluting stents for coronary in-stent restenosis","volume":"47","author":"Cortese","year":"2026","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvir.2026.108987_bib22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12928-023-00921-2","article-title":"Clinical expert consensus document on drug-coated balloon for coronary artery disease from the Japanese association of cardiovascular intervention and therapeutics","volume":"38","author":"Muramatsu","year":"2023","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.jvir.2026.108987_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10370","article-title":"Understudied factors in drug-coated balloon design and evaluation: a biophysical perspective","volume":"8","author":"Shazly","year":"2023","journal-title":"Bioeng Transl Med"},{"key":"10.1016\/j.jvir.2026.108987_bib24","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jvir.2025.01.033","article-title":"Comparison of 2 paclitaxel-coated balloons with different excipients for the treatment of femoropopliteal artery disease: a randomized prospective trial","volume":"36","author":"Choi","year":"2025","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2026.108987_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-080881","article-title":"Plain versus drug balloon and stenting in severe ischaemia of the leg (BASIL-3): open label, three arm, randomised, multicentre, phase 3 trial","volume":"388","author":"Bradbury","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.jvir.2026.108987_bib26","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/eurheartj\/ehac722","article-title":"Endovascular revascularization strategies for aortoiliac and femoropopliteal artery disease: a meta-analysis","volume":"44","author":"Koeckerling","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvir.2026.108987_bib27","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jvs.2025.11.020","article-title":"Clinical outcome of endovascular therapy for femoropopliteal artery lesions in patients with intermittent claudication: twenty-four-month outcomes from the TALENT registry","volume":"83","author":"Wang","year":"2026","journal-title":"J Vasc Surg"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105104432600998X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105104432600998X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:15:15Z","timestamp":1792725315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105104432600998X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S105104432600998X"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2026.108987","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-Eluting Stents versus Drug-Coated Balloons Plus Bare-Metal Stents for the Treatment of Femoropopliteal Artery Lesions: 2-Year Outcomes from the TALENT Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvir.2026.108987","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 SIR, 2026","name":"copyright","label":"Copyright"}],"article-number":"108987"}}